| Melphalan investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 272show all (up to 200) |
|---|
| → investigated in trials for | Multiple Myelomahematologic_malignancy 172 trials (21 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Multiple Myeloma | 172 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lymphoma 109 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lymphoma | 109 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Myelodysplastic Syndrome 86 trials (26 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Myelodysplastic Syndrome | 86 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leukemia 67 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Leukemia | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acute Myeloid Leukemiahematologic_malignancy 53 trials (24 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Acute Myeloid Leukemia | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neuroblastomasubtype 39 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Neuroblastoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Non-Hodgkin Lymphomahematologic_malignancy 37 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Non-Hodgkin Lymphoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acute Lymphoblastic Leukemiahematologic_malignancy 36 trials (16 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Acute Lymphoblastic Leukemia | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hodgkin Lymphomahematologic_malignancy 31 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hodgkin Lymphoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chronic Lymphocytic Leukemia 22 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Chronic Lymphocytic Leukemia | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic and Lymphoid Cell Neoplasm 21 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Myeloproliferative Neoplasm 20 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Myeloproliferative Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mantle Cell Lymphoma 17 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Mantle Cell Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Myelodysplastic/Myeloproliferative Neoplasm 16 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Myelodysplastic/Myeloproliferative Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chronic Myeloid Leukemia, BCR-ABL1 Positive 15 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 15 | Observed | clinicaltrials | graph → |